Regen BioPharma RGBP Stock
Regen BioPharma Price Chart
Regen BioPharma RGBP Financial and Trading Overview
| Regen BioPharma stock price | 0.0002 USD |
| Previous Close | 0.0002 USD |
| Open | 0.0001 USD |
| Bid | 0.0001 USD x 73618398200 |
| Ask | 0.0002 USD x 17480348400 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.12 USD |
| Volume | 16 USD |
| Avg. Volume | 16.49M USD |
| Market Cap | 102.39K USD |
| Beta (5Y Monthly) | 0.186 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGBP Valuation Measures
| Enterprise Value | 1.08M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.4328331 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.552 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Regen BioPharma Stock Price History
| Beta (5Y Monthly) | 0.186 |
| 52-Week Change | -99.57% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.12 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000374 USD |
| 200-Day Moving Average | 0.0060481 USD |
RGBP Share Statistics
| Avg. Volume (3 month) | 16.49M USD |
| Avg. Daily Volume (10-Days) | 28.11M USD |
| Shares Outstanding | 511.96M |
| Float | 465.7M |
| Short Ratio | N/A |
| % Held by Insiders | 9.91% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -260.23% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -252.85% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 236.56K USD |
| Revenue Per Share (ttm) | 0.003 USD |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | 236.56K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -715689 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 271 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 959.15K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.046 |
| Book Value Per Share (mrq) | -0.015 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -477157 USD |
| Levered Free Cash Flow (ttm) | -436287 USD |
Profile of Regen BioPharma
| Country | United States |
| State | CA |
| City | La Mesa |
| Address | 8697 La Mesa Boulevard |
| ZIP | 91942 |
| Phone | 619 722 5505 |
| Website | https://regenbiopharmainc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune diseases. It also develops several products: HemaXellarate, a cellular therapeutic product derived from autologous stromal vascular fraction from adipose tissue; dCellVax, an autologous dendritic cell treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax, which is treated with siRNA to inhibit NR2F6, with the cells re-infused into the patient; DiffronC, which uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuraCAR, comprising CAR-T cells treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California.
Q&A For Regen BioPharma Stock
What is a current RGBP stock price?
Regen BioPharma RGBP stock price today per share is 0.0002 USD.
How to purchase Regen BioPharma stock?
You can buy RGBP shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Regen BioPharma?
The stock symbol or ticker of Regen BioPharma is RGBP.
Which industry does the Regen BioPharma company belong to?
The Regen BioPharma industry is Biotechnology.
How many shares does Regen BioPharma have in circulation?
The max supply of Regen BioPharma shares is 383.97M.
What is Regen BioPharma Price to Earnings Ratio (PE Ratio)?
Regen BioPharma PE Ratio is now.
What was Regen BioPharma earnings per share over the trailing 12 months (TTM)?
Regen BioPharma EPS is -0.02 USD over the trailing 12 months.
Which sector does the Regen BioPharma company belong to?
The Regen BioPharma sector is Healthcare.